Citation Tools

Download PDFPDF

Original article
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

Download to a citation manager

Cite this article as:
Baraliakos X, Braun J, Deodhar A on behalf of the MEASURE 1 study group, et al
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study